주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-19 17:28 (Tues)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
4,346 )
기사목록 보기 형태
제목형
요약형
포토형
Exodus of medical residents forces neurological society to cancel workshop
You Ji-young
2024.03.12 13:19
Confusion reigns from day 1 of putting public health doctors in teaching hospitals
Kim Ju-yeon
2024.03.12 11:18
[Column] Why it's better to buy twigim instead of cooking it at home
Jeong Jae-hoon
2024.03.12 09:51
Breakthrough soft artificial retina offers safe vision restoration for the visually impaired
Lee Han-soo
2024.03.12 09:44
Korean biopharma firms to showcase latest research at US cancer meet AACR 2024
Lee Han-soo
2024.03.12 09:31
NCC licenses out pancreatic cancer biomarker to New Cancer Cure Bio
Lee Han-soo
2024.03.11 16:28
Hanmi Pharm applies for phase 1 trial of obesity drug HM15275
Kim Chan-hyuk
2024.03.11 16:21
Court to decide whether to suspend medical student increase as early as Friday this week
Koh Jung Min
2024.03.11 16:14
ST Pharm, LegoChem Biosciences team up for ADC linker manufacturing, research
Lee Han-soo
2024.03.11 16:06
Celltrion completes FDA submission for Xolair biosimilar
Lee Han-soo
2024.03.11 14:43
Keytruda approved as 1st-line treatment for HER2-negative gastric cancer to vie with Opdivo
Kim Chan-hyuk
2024.03.11 13:24
GSK's Jemperli beats MSD's Keytruda to become 1st-line treatment for endometrial cancer in Korea
Kim Chan-hyuk
2024.03.11 13:21
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기